0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Atropine Sulfate for Injection Market Research Report 2026
Published Date: 2026-01-28
|
Report Code: QYRE-Auto-29F18371
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Atropine Sulfate for Injection Market Research Report 2024
BUY CHAPTERS

Global Atropine Sulfate for Injection Market Research Report 2026

Code: QYRE-Auto-29F18371
Report
2026-01-28
Pages:128
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Atropine Sulfate for Injection Market Size

The global Atropine Sulfate for Injection market was valued at US$ 389 million in 2025 and is anticipated to reach US$ 591 million by 2032, at a CAGR of 6.3% from 2026 to 2032.

Atropine Sulfate for Injection Market

Atropine Sulfate for Injection Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Atropine Sulfate for Injection competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Atropine Sulfate for Injection is a sterile powder or solution form of the drug that needs to be dissolved and administered by intravenous or intramuscular injection. Its main ingredient is atropine sulfate, which has a wide range of clinical applications.
The North American market for Atropine Sulfate for Injection is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Atropine Sulfate for Injection is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Atropine Sulfate for Injection include Pfizer, American Regent, Hikma Pharmaceuticals, Apotex, Amneal Pharmaceuticals, Accord Healthcare, China Res Double-Crane, Hebei Kaiwei Pharmaceutical, Hebei Tiancheng Pharmaceutical, Tai Yu Chemical & Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Atropine Sulfate for Injection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Atropine Sulfate for Injection. The Atropine Sulfate for Injection market size, estimates, and forecasts are provided in terms of sales volume (K Dose) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Atropine Sulfate for Injection market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Atropine Sulfate for Injection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Atropine Sulfate for Injection Market Report

Report Metric Details
Report Name Atropine Sulfate for Injection Market
Accounted market size in 2025 US$ 389 million
Forecasted market size in 2032 US$ 591 million
CAGR 6.3%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • 0.5 mg/mL
  • 1 mg/mL
  • 5 mg/ml
  • Others
by Application
  • Online Sales
  • Offline Sales
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, American Regent, Hikma Pharmaceuticals, Apotex, Amneal Pharmaceuticals, Accord Healthcare, China Res Double-Crane, Hebei Kaiwei Pharmaceutical, Hebei Tiancheng Pharmaceutical, Tai Yu Chemical & Pharmaceutical, Tianjin Jinyao Pharmaceutical, Sunflower Pharmaceutical, China Shineway Pharm, CSPC Ouyi Pharmaceutical, Suicheng Pharmaceutical, Chengdu Brilliant Pharmaceutical, Anhui Changjiang Pharmaceutical, Shanghai Harvest Pharmaceutical, Hubei Xinghua Pharmaceutical, Changzhou Pharmaceutical Factory
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Atropine Sulfate for Injection manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Atropine Sulfate for Injection sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Atropine Sulfate for Injection Market growing?

Ans: The Atropine Sulfate for Injection Market witnessing a CAGR of 6.3% during the forecast period 2026-2032.

What is the Atropine Sulfate for Injection Market size in 2032?

Ans: The Atropine Sulfate for Injection Market size in 2032 will be US$ 591 million.

Who are the main players in the Atropine Sulfate for Injection Market report?

Ans: The main players in the Atropine Sulfate for Injection Market are Pfizer, American Regent, Hikma Pharmaceuticals, Apotex, Amneal Pharmaceuticals, Accord Healthcare, China Res Double-Crane, Hebei Kaiwei Pharmaceutical, Hebei Tiancheng Pharmaceutical, Tai Yu Chemical & Pharmaceutical, Tianjin Jinyao Pharmaceutical, Sunflower Pharmaceutical, China Shineway Pharm, CSPC Ouyi Pharmaceutical, Suicheng Pharmaceutical, Chengdu Brilliant Pharmaceutical, Anhui Changjiang Pharmaceutical, Shanghai Harvest Pharmaceutical, Hubei Xinghua Pharmaceutical, Changzhou Pharmaceutical Factory

What are the Application segmentation covered in the Atropine Sulfate for Injection Market report?

Ans: The Applications covered in the Atropine Sulfate for Injection Market report are Online Sales, Offline Sales

What are the Type segmentation covered in the Atropine Sulfate for Injection Market report?

Ans: The Types covered in the Atropine Sulfate for Injection Market report are 0.5 mg/mL, 1 mg/mL, 5 mg/ml, Others

1 Atropine Sulfate for Injection Market Overview
1.1 Product Definition
1.2 Atropine Sulfate for Injection by Type
1.2.1 Global Atropine Sulfate for Injection Market Value by Type: 2025 vs 2032
1.2.2 0.5 mg/mL
1.2.3 1 mg/mL
1.2.4 5 mg/ml
1.2.5 Others
1.3 Atropine Sulfate for Injection by Application
1.3.1 Global Atropine Sulfate for Injection Market Value by Application: 2025 vs 2032
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global Atropine Sulfate for Injection Market Size Estimates and Forecasts
1.4.1 Global Atropine Sulfate for Injection Revenue 2021–2032
1.4.2 Global Atropine Sulfate for Injection Sales 2021–2032
1.4.3 Global Atropine Sulfate for Injection Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Atropine Sulfate for Injection Market Competition by Manufacturers
2.1 Global Atropine Sulfate for Injection Sales Market Share by Manufacturers (2021–2026)
2.2 Global Atropine Sulfate for Injection Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Atropine Sulfate for Injection Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Atropine Sulfate for Injection, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Atropine Sulfate for Injection, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Atropine Sulfate for Injection, Product Types and Applications
2.7 Global Key Manufacturers of Atropine Sulfate for Injection, Date of Entry into the Industry
2.8 Global Atropine Sulfate for Injection Market Competitive Situation and Trends
2.8.1 Global Atropine Sulfate for Injection Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Atropine Sulfate for Injection Players Market Share by Revenue
2.8.3 Global Atropine Sulfate for Injection Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Atropine Sulfate for Injection Market Scenario by Region
3.1 Global Atropine Sulfate for Injection Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Atropine Sulfate for Injection Sales by Region: 2021–2032
3.2.1 Global Atropine Sulfate for Injection Sales by Region: 2021–2026
3.2.2 Global Atropine Sulfate for Injection Sales by Region: 2027–2032
3.3 Global Atropine Sulfate for Injection Revenue by Region: 2021–2032
3.3.1 Global Atropine Sulfate for Injection Revenue by Region: 2021–2026
3.3.2 Global Atropine Sulfate for Injection Revenue by Region: 2027–2032
3.4 North America Atropine Sulfate for Injection Market Facts & Figures by Country
3.4.1 North America Atropine Sulfate for Injection Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Atropine Sulfate for Injection Sales by Country (2021–2032)
3.4.3 North America Atropine Sulfate for Injection Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Atropine Sulfate for Injection Market Facts & Figures by Country
3.5.1 Europe Atropine Sulfate for Injection Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Atropine Sulfate for Injection Sales by Country (2021–2032)
3.5.3 Europe Atropine Sulfate for Injection Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Atropine Sulfate for Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Atropine Sulfate for Injection Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Atropine Sulfate for Injection Sales by Region (2021–2032)
3.6.3 Asia Pacific Atropine Sulfate for Injection Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Atropine Sulfate for Injection Market Facts & Figures by Country
3.7.1 Latin America Atropine Sulfate for Injection Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Atropine Sulfate for Injection Sales by Country (2021–2032)
3.7.3 Latin America Atropine Sulfate for Injection Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Atropine Sulfate for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Atropine Sulfate for Injection Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Atropine Sulfate for Injection Sales by Country (2021–2032)
3.8.3 Middle East and Africa Atropine Sulfate for Injection Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Atropine Sulfate for Injection Sales by Type (2021–2032)
4.1.1 Global Atropine Sulfate for Injection Sales by Type (2021–2026)
4.1.2 Global Atropine Sulfate for Injection Sales by Type (2027–2032)
4.1.3 Global Atropine Sulfate for Injection Sales Market Share by Type (2021–2032)
4.2 Global Atropine Sulfate for Injection Revenue by Type (2021–2032)
4.2.1 Global Atropine Sulfate for Injection Revenue by Type (2021–2026)
4.2.2 Global Atropine Sulfate for Injection Revenue by Type (2027–2032)
4.2.3 Global Atropine Sulfate for Injection Revenue Market Share by Type (2021–2032)
4.3 Global Atropine Sulfate for Injection Price by Type (2021–2032)
5 Segment by Application
5.1 Global Atropine Sulfate for Injection Sales by Application (2021–2032)
5.1.1 Global Atropine Sulfate for Injection Sales by Application (2021–2026)
5.1.2 Global Atropine Sulfate for Injection Sales by Application (2027–2032)
5.1.3 Global Atropine Sulfate for Injection Sales Market Share by Application (2021–2032)
5.2 Global Atropine Sulfate for Injection Revenue by Application (2021–2032)
5.2.1 Global Atropine Sulfate for Injection Revenue by Application (2021–2026)
5.2.2 Global Atropine Sulfate for Injection Revenue by Application (2027–2032)
5.2.3 Global Atropine Sulfate for Injection Revenue Market Share by Application (2021–2032)
5.3 Global Atropine Sulfate for Injection Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Pfizer Atropine Sulfate for Injection Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 American Regent
6.2.1 American Regent Company Information
6.2.2 American Regent Description and Business Overview
6.2.3 American Regent Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 American Regent Atropine Sulfate for Injection Product Portfolio
6.2.5 American Regent Recent Developments/Updates
6.3 Hikma Pharmaceuticals
6.3.1 Hikma Pharmaceuticals Company Information
6.3.2 Hikma Pharmaceuticals Description and Business Overview
6.3.3 Hikma Pharmaceuticals Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Hikma Pharmaceuticals Atropine Sulfate for Injection Product Portfolio
6.3.5 Hikma Pharmaceuticals Recent Developments/Updates
6.4 Apotex
6.4.1 Apotex Company Information
6.4.2 Apotex Description and Business Overview
6.4.3 Apotex Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Apotex Atropine Sulfate for Injection Product Portfolio
6.4.5 Apotex Recent Developments/Updates
6.5 Amneal Pharmaceuticals
6.5.1 Amneal Pharmaceuticals Company Information
6.5.2 Amneal Pharmaceuticals Description and Business Overview
6.5.3 Amneal Pharmaceuticals Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Amneal Pharmaceuticals Atropine Sulfate for Injection Product Portfolio
6.5.5 Amneal Pharmaceuticals Recent Developments/Updates
6.6 Accord Healthcare
6.6.1 Accord Healthcare Company Information
6.6.2 Accord Healthcare Description and Business Overview
6.6.3 Accord Healthcare Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Accord Healthcare Atropine Sulfate for Injection Product Portfolio
6.6.5 Accord Healthcare Recent Developments/Updates
6.7 China Res Double-Crane
6.7.1 China Res Double-Crane Company Information
6.7.2 China Res Double-Crane Description and Business Overview
6.7.3 China Res Double-Crane Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 China Res Double-Crane Atropine Sulfate for Injection Product Portfolio
6.7.5 China Res Double-Crane Recent Developments/Updates
6.8 Hebei Kaiwei Pharmaceutical
6.8.1 Hebei Kaiwei Pharmaceutical Company Information
6.8.2 Hebei Kaiwei Pharmaceutical Description and Business Overview
6.8.3 Hebei Kaiwei Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Hebei Kaiwei Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.8.5 Hebei Kaiwei Pharmaceutical Recent Developments/Updates
6.9 Hebei Tiancheng Pharmaceutical
6.9.1 Hebei Tiancheng Pharmaceutical Company Information
6.9.2 Hebei Tiancheng Pharmaceutical Description and Business Overview
6.9.3 Hebei Tiancheng Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Hebei Tiancheng Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.9.5 Hebei Tiancheng Pharmaceutical Recent Developments/Updates
6.10 Tai Yu Chemical & Pharmaceutical
6.10.1 Tai Yu Chemical & Pharmaceutical Company Information
6.10.2 Tai Yu Chemical & Pharmaceutical Description and Business Overview
6.10.3 Tai Yu Chemical & Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Tai Yu Chemical & Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.10.5 Tai Yu Chemical & Pharmaceutical Recent Developments/Updates
6.11 Tianjin Jinyao Pharmaceutical
6.11.1 Tianjin Jinyao Pharmaceutical Company Information
6.11.2 Tianjin Jinyao Pharmaceutical Description and Business Overview
6.11.3 Tianjin Jinyao Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Tianjin Jinyao Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.11.5 Tianjin Jinyao Pharmaceutical Recent Developments/Updates
6.12 Sunflower Pharmaceutical
6.12.1 Sunflower Pharmaceutical Company Information
6.12.2 Sunflower Pharmaceutical Description and Business Overview
6.12.3 Sunflower Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Sunflower Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.12.5 Sunflower Pharmaceutical Recent Developments/Updates
6.13 China Shineway Pharm
6.13.1 China Shineway Pharm Company Information
6.13.2 China Shineway Pharm Description and Business Overview
6.13.3 China Shineway Pharm Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 China Shineway Pharm Atropine Sulfate for Injection Product Portfolio
6.13.5 China Shineway Pharm Recent Developments/Updates
6.14 CSPC Ouyi Pharmaceutical
6.14.1 CSPC Ouyi Pharmaceutical Company Information
6.14.2 CSPC Ouyi Pharmaceutical Description and Business Overview
6.14.3 CSPC Ouyi Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 CSPC Ouyi Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.14.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates
6.15 Suicheng Pharmaceutical
6.15.1 Suicheng Pharmaceutical Company Information
6.15.2 Suicheng Pharmaceutical Description and Business Overview
6.15.3 Suicheng Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Suicheng Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.15.5 Suicheng Pharmaceutical Recent Developments/Updates
6.16 Chengdu Brilliant Pharmaceutical
6.16.1 Chengdu Brilliant Pharmaceutical Company Information
6.16.2 Chengdu Brilliant Pharmaceutical Description and Business Overview
6.16.3 Chengdu Brilliant Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Chengdu Brilliant Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.16.5 Chengdu Brilliant Pharmaceutical Recent Developments/Updates
6.17 Anhui Changjiang Pharmaceutical
6.17.1 Anhui Changjiang Pharmaceutical Company Information
6.17.2 Anhui Changjiang Pharmaceutical Description and Business Overview
6.17.3 Anhui Changjiang Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Anhui Changjiang Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.17.5 Anhui Changjiang Pharmaceutical Recent Developments/Updates
6.18 Shanghai Harvest Pharmaceutical
6.18.1 Shanghai Harvest Pharmaceutical Company Information
6.18.2 Shanghai Harvest Pharmaceutical Description and Business Overview
6.18.3 Shanghai Harvest Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Shanghai Harvest Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.18.5 Shanghai Harvest Pharmaceutical Recent Developments/Updates
6.19 Hubei Xinghua Pharmaceutical
6.19.1 Hubei Xinghua Pharmaceutical Company Information
6.19.2 Hubei Xinghua Pharmaceutical Description and Business Overview
6.19.3 Hubei Xinghua Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Hubei Xinghua Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.19.5 Hubei Xinghua Pharmaceutical Recent Developments/Updates
6.20 Changzhou Pharmaceutical Factory
6.20.1 Changzhou Pharmaceutical Factory Company Information
6.20.2 Changzhou Pharmaceutical Factory Description and Business Overview
6.20.3 Changzhou Pharmaceutical Factory Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Changzhou Pharmaceutical Factory Atropine Sulfate for Injection Product Portfolio
6.20.5 Changzhou Pharmaceutical Factory Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Atropine Sulfate for Injection Industry Chain Analysis
7.2 Atropine Sulfate for Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Atropine Sulfate for Injection Production Mode & Process Analysis
7.4 Atropine Sulfate for Injection Sales and Marketing
7.4.1 Atropine Sulfate for Injection Sales Channels
7.4.2 Atropine Sulfate for Injection Distributors
7.5 Atropine Sulfate for Injection Customer Analysis
8 Atropine Sulfate for Injection Market Dynamics
8.1 Atropine Sulfate for Injection Industry Trends
8.2 Atropine Sulfate for Injection Market Drivers
8.3 Atropine Sulfate for Injection Market Challenges
8.4 Atropine Sulfate for Injection Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Atropine Sulfate for Injection Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Atropine Sulfate for Injection Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Atropine Sulfate for Injection Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Atropine Sulfate for Injection Sales (K Dose) of Key Manufacturers (2021–2026)
 Table 5. Global Atropine Sulfate for Injection Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Atropine Sulfate for Injection Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Atropine Sulfate for Injection Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Atropine Sulfate for Injection Average Price (US$/Dose) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Atropine Sulfate for Injection, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Atropine Sulfate for Injection, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Atropine Sulfate for Injection, Product Types and Applications
 Table 12. Global Key Manufacturers of Atropine Sulfate for Injection, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Atropine Sulfate for Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Atropine Sulfate for Injection Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Atropine Sulfate for Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Atropine Sulfate for Injection Sales by Region (K Dose), 2021–2026
 Table 18. Global Atropine Sulfate for Injection Sales Market Share by Region (2021–2026)
 Table 19. Global Atropine Sulfate for Injection Sales by Region (K Dose), 2027–2032
 Table 20. Global Atropine Sulfate for Injection Sales Market Share by Region (2027–2032)
 Table 21. Global Atropine Sulfate for Injection Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Atropine Sulfate for Injection Revenue Market Share by Region (2021–2026)
 Table 23. Global Atropine Sulfate for Injection Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Atropine Sulfate for Injection Revenue Market Share by Region (2027–2032)
 Table 25. North America Atropine Sulfate for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Atropine Sulfate for Injection Sales by Country (K Dose), 2021–2026
 Table 27. North America Atropine Sulfate for Injection Sales by Country (K Dose), 2027–2032
 Table 28. North America Atropine Sulfate for Injection Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Atropine Sulfate for Injection Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Atropine Sulfate for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Atropine Sulfate for Injection Sales by Country (K Dose), 2021–2026
 Table 32. Europe Atropine Sulfate for Injection Sales by Country (K Dose), 2027–2032
 Table 33. Europe Atropine Sulfate for Injection Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Atropine Sulfate for Injection Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Atropine Sulfate for Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Atropine Sulfate for Injection Sales by Region (K Dose), 2021–2026
 Table 37. Asia Pacific Atropine Sulfate for Injection Sales by Region (K Dose), 2027–2032
 Table 38. Asia Pacific Atropine Sulfate for Injection Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Atropine Sulfate for Injection Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Atropine Sulfate for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Atropine Sulfate for Injection Sales by Country (K Dose), 2021–2026
 Table 42. Latin America Atropine Sulfate for Injection Sales by Country (K Dose), 2027–2032
 Table 43. Latin America Atropine Sulfate for Injection Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Atropine Sulfate for Injection Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Atropine Sulfate for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Atropine Sulfate for Injection Sales by Country (K Dose), 2021–2026
 Table 47. Middle East and Africa Atropine Sulfate for Injection Sales by Country (K Dose), 2027–2032
 Table 48. Middle East and Africa Atropine Sulfate for Injection Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Atropine Sulfate for Injection Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Atropine Sulfate for Injection Sales (K Dose) by Type (2021–2026)
 Table 51. Global Atropine Sulfate for Injection Sales (K Dose) by Type (2027–2032)
 Table 52. Global Atropine Sulfate for Injection Sales Market Share by Type (2021–2026)
 Table 53. Global Atropine Sulfate for Injection Sales Market Share by Type (2027–2032)
 Table 54. Global Atropine Sulfate for Injection Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Atropine Sulfate for Injection Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Atropine Sulfate for Injection Revenue Market Share by Type (2021–2026)
 Table 57. Global Atropine Sulfate for Injection Revenue Market Share by Type (2027–2032)
 Table 58. Global Atropine Sulfate for Injection Price (US$/Dose) by Type (2021–2026)
 Table 59. Global Atropine Sulfate for Injection Price (US$/Dose) by Type (2027–2032)
 Table 60. Global Atropine Sulfate for Injection Sales (K Dose) by Application (2021–2026)
 Table 61. Global Atropine Sulfate for Injection Sales (K Dose) by Application (2027–2032)
 Table 62. Global Atropine Sulfate for Injection Sales Market Share by Application (2021–2026)
 Table 63. Global Atropine Sulfate for Injection Sales Market Share by Application (2027–2032)
 Table 64. Global Atropine Sulfate for Injection Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Atropine Sulfate for Injection Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Atropine Sulfate for Injection Revenue Market Share by Application (2021–2026)
 Table 67. Global Atropine Sulfate for Injection Revenue Market Share by Application (2027–2032)
 Table 68. Global Atropine Sulfate for Injection Price (US$/Dose) by Application (2021–2026)
 Table 69. Global Atropine Sulfate for Injection Price (US$/Dose) by Application (2027–2032)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 73. Pfizer Atropine Sulfate for Injection Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. American Regent Company Information
 Table 76. American Regent Description and Business Overview
 Table 77. American Regent Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 78. American Regent Atropine Sulfate for Injection Product
 Table 79. American Regent Recent Developments/Updates
 Table 80. Hikma Pharmaceuticals Company Information
 Table 81. Hikma Pharmaceuticals Description and Business Overview
 Table 82. Hikma Pharmaceuticals Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 83. Hikma Pharmaceuticals Atropine Sulfate for Injection Product
 Table 84. Hikma Pharmaceuticals Recent Developments/Updates
 Table 85. Apotex Company Information
 Table 86. Apotex Description and Business Overview
 Table 87. Apotex Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 88. Apotex Atropine Sulfate for Injection Product
 Table 89. Apotex Recent Developments/Updates
 Table 90. Amneal Pharmaceuticals Company Information
 Table 91. Amneal Pharmaceuticals Description and Business Overview
 Table 92. Amneal Pharmaceuticals Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 93. Amneal Pharmaceuticals Atropine Sulfate for Injection Product
 Table 94. Amneal Pharmaceuticals Recent Developments/Updates
 Table 95. Accord Healthcare Company Information
 Table 96. Accord Healthcare Description and Business Overview
 Table 97. Accord Healthcare Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 98. Accord Healthcare Atropine Sulfate for Injection Product
 Table 99. Accord Healthcare Recent Developments/Updates
 Table 100. China Res Double-Crane Company Information
 Table 101. China Res Double-Crane Description and Business Overview
 Table 102. China Res Double-Crane Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 103. China Res Double-Crane Atropine Sulfate for Injection Product
 Table 104. China Res Double-Crane Recent Developments/Updates
 Table 105. Hebei Kaiwei Pharmaceutical Company Information
 Table 106. Hebei Kaiwei Pharmaceutical Description and Business Overview
 Table 107. Hebei Kaiwei Pharmaceutical Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 108. Hebei Kaiwei Pharmaceutical Atropine Sulfate for Injection Product
 Table 109. Hebei Kaiwei Pharmaceutical Recent Developments/Updates
 Table 110. Hebei Tiancheng Pharmaceutical Company Information
 Table 111. Hebei Tiancheng Pharmaceutical Description and Business Overview
 Table 112. Hebei Tiancheng Pharmaceutical Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 113. Hebei Tiancheng Pharmaceutical Atropine Sulfate for Injection Product
 Table 114. Hebei Tiancheng Pharmaceutical Recent Developments/Updates
 Table 115. Tai Yu Chemical & Pharmaceutical Company Information
 Table 116. Tai Yu Chemical & Pharmaceutical Description and Business Overview
 Table 117. Tai Yu Chemical & Pharmaceutical Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 118. Tai Yu Chemical & Pharmaceutical Atropine Sulfate for Injection Product
 Table 119. Tai Yu Chemical & Pharmaceutical Recent Developments/Updates
 Table 120. Tianjin Jinyao Pharmaceutical Company Information
 Table 121. Tianjin Jinyao Pharmaceutical Description and Business Overview
 Table 122. Tianjin Jinyao Pharmaceutical Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 123. Tianjin Jinyao Pharmaceutical Atropine Sulfate for Injection Product
 Table 124. Tianjin Jinyao Pharmaceutical Recent Developments/Updates
 Table 125. Sunflower Pharmaceutical Company Information
 Table 126. Sunflower Pharmaceutical Description and Business Overview
 Table 127. Sunflower Pharmaceutical Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 128. Sunflower Pharmaceutical Atropine Sulfate for Injection Product
 Table 129. Sunflower Pharmaceutical Recent Developments/Updates
 Table 130. China Shineway Pharm Company Information
 Table 131. China Shineway Pharm Description and Business Overview
 Table 132. China Shineway Pharm Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 133. China Shineway Pharm Atropine Sulfate for Injection Product
 Table 134. China Shineway Pharm Recent Developments/Updates
 Table 135. CSPC Ouyi Pharmaceutical Company Information
 Table 136. CSPC Ouyi Pharmaceutical Description and Business Overview
 Table 137. CSPC Ouyi Pharmaceutical Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 138. CSPC Ouyi Pharmaceutical Atropine Sulfate for Injection Product
 Table 139. CSPC Ouyi Pharmaceutical Recent Developments/Updates
 Table 140. Suicheng Pharmaceutical Company Information
 Table 141. Suicheng Pharmaceutical Description and Business Overview
 Table 142. Suicheng Pharmaceutical Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 143. Suicheng Pharmaceutical Atropine Sulfate for Injection Product
 Table 144. Suicheng Pharmaceutical Recent Developments/Updates
 Table 145. Chengdu Brilliant Pharmaceutical Company Information
 Table 146. Chengdu Brilliant Pharmaceutical Description and Business Overview
 Table 147. Chengdu Brilliant Pharmaceutical Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 148. Chengdu Brilliant Pharmaceutical Atropine Sulfate for Injection Product
 Table 149. Chengdu Brilliant Pharmaceutical Recent Developments/Updates
 Table 150. Anhui Changjiang Pharmaceutical Company Information
 Table 151. Anhui Changjiang Pharmaceutical Description and Business Overview
 Table 152. Anhui Changjiang Pharmaceutical Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 153. Anhui Changjiang Pharmaceutical Atropine Sulfate for Injection Product
 Table 154. Anhui Changjiang Pharmaceutical Recent Developments/Updates
 Table 155. Shanghai Harvest Pharmaceutical Company Information
 Table 156. Shanghai Harvest Pharmaceutical Description and Business Overview
 Table 157. Shanghai Harvest Pharmaceutical Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 158. Shanghai Harvest Pharmaceutical Atropine Sulfate for Injection Product
 Table 159. Shanghai Harvest Pharmaceutical Recent Developments/Updates
 Table 160. Hubei Xinghua Pharmaceutical Company Information
 Table 161. Hubei Xinghua Pharmaceutical Description and Business Overview
 Table 162. Hubei Xinghua Pharmaceutical Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 163. Hubei Xinghua Pharmaceutical Atropine Sulfate for Injection Product
 Table 164. Hubei Xinghua Pharmaceutical Recent Developments/Updates
 Table 165. Changzhou Pharmaceutical Factory Company Information
 Table 166. Changzhou Pharmaceutical Factory Description and Business Overview
 Table 167. Changzhou Pharmaceutical Factory Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 168. Changzhou Pharmaceutical Factory Atropine Sulfate for Injection Product
 Table 169. Changzhou Pharmaceutical Factory Recent Developments/Updates
 Table 170. Key Raw Materials Lists
 Table 171. Raw Materials Key Suppliers Lists
 Table 172. Atropine Sulfate for Injection Distributors List
 Table 173. Atropine Sulfate for Injection Customers List
 Table 174. Atropine Sulfate for Injection Market Trends
 Table 175. Atropine Sulfate for Injection Market Drivers
 Table 176. Atropine Sulfate for Injection Market Challenges
 Table 177. Atropine Sulfate for Injection Market Restraints
 Table 178. Research Programs/Design for This Report
 Table 179. Key Data Information from Secondary Sources
 Table 180. Key Data Information from Primary Sources
 Table 181. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Atropine Sulfate for Injection
 Figure 2. Global Atropine Sulfate for Injection Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Atropine Sulfate for Injection Market Share by Type: 2025 & 2032
 Figure 4. 0.5 mg/mL Product Picture
 Figure 5. 1 mg/mL Product Picture
 Figure 6. 5 mg/ml Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Atropine Sulfate for Injection Market Value by Application (US$ Million), 2021–2032
 Figure 9. Global Atropine Sulfate for Injection Market Share by Application: 2025 & 2032
 Figure 10. Online Sales
 Figure 11. Offline Sales
 Figure 12. Global Atropine Sulfate for Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Atropine Sulfate for Injection Market Size (US$ Million), 2021–2032
 Figure 14. Global Atropine Sulfate for Injection Sales (K Dose), 2021–2032
 Figure 15. Global Atropine Sulfate for Injection Average Price (US$/Dose), 2021–2032
 Figure 16. Atropine Sulfate for Injection Report Years Considered
 Figure 17. Atropine Sulfate for Injection Sales Share by Manufacturers in 2025
 Figure 18. Global Atropine Sulfate for Injection Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Atropine Sulfate for Injection Players: Market Share by Revenue in Atropine Sulfate for Injection in 2025
 Figure 20. Atropine Sulfate for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Atropine Sulfate for Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Atropine Sulfate for Injection Sales Market Share by Country (2021–2032)
 Figure 23. North America Atropine Sulfate for Injection Revenue Market Share by Country (2021–2032)
 Figure 24. United States Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Atropine Sulfate for Injection Sales Market Share by Country (2021–2032)
 Figure 27. Europe Atropine Sulfate for Injection Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Atropine Sulfate for Injection Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Atropine Sulfate for Injection Revenue Market Share by Region (2021–2032)
 Figure 35. China Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Southeast Asia Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America Atropine Sulfate for Injection Sales Market Share by Country (2021–2032)
 Figure 43. Latin America Atropine Sulfate for Injection Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Colombia Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Atropine Sulfate for Injection Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Atropine Sulfate for Injection Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Atropine Sulfate for Injection by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Atropine Sulfate for Injection by Type (2021–2032)
 Figure 55. Global Atropine Sulfate for Injection Price (US$/Dose) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Atropine Sulfate for Injection by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Atropine Sulfate for Injection by Application (2021–2032)
 Figure 58. Global Atropine Sulfate for Injection Price (US$/Dose) by Application (2021–2032)
 Figure 59. Atropine Sulfate for Injection Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network